Mimcipar 30mg Tablet

Mimcipar 30mg Tablet contains Cinacalcet as its active ingredient. Cinacalcet is a medication used to treat secondary hyperparathyroidism in patients with chronic kidney disease and parathyroid carcinoma. It works by increasing the sensitivity of calcium-sensing receptors on the parathyroid gland, leading to decreased production of parathyroid hormone (PTH) and consequently lowering elevated levels of calcium in the blood.

Uses:

Mimcipar 30mg Tablet is primarily used for the management of secondary hyperparathyroidism in patients with chronic kidney disease on dialysis and for the treatment of hypercalcemia associated with parathyroid carcinoma. By regulating parathyroid hormone levels and calcium metabolism, Cinacalcet helps maintain normal bone health and serum calcium levels in these patients.

Benefits:

The primary benefit of Mimcipar 30mg Tablet is its ability to effectively lower elevated levels of parathyroid hormone and calcium in patients with secondary hyperparathyroidism and parathyroid carcinoma. By normalizing calcium metabolism, it helps prevent complications such as bone disease, cardiovascular calcification, and other complications associated with abnormal calcium levels.

Usage Instructions:

Mimcipar 30mg Tablet is usually taken orally, once daily, with or without food. The dosage may vary depending on the patient’s condition, kidney function, and response to treatment. It is essential to follow the instructions provided by the healthcare provider or as indicated on the medication label. Regular monitoring of calcium and PTH levels is necessary during treatment.

Precautions:

Before using Mimcipar 30mg Tablet, inform your healthcare provider about any medical conditions you may have, especially liver disease or seizures. Use caution when driving or operating machinery, as Cinacalcet may cause dizziness or lightheadedness. Inform your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding, as the use of Cinacalcet during pregnancy and lactation is not well studied.

Side Effects:

Common side effects of Mimcipar 30mg Tablet may include nausea, vomiting, diarrhea, headache, and dizziness. Less common but more severe side effects may include hypocalcemia (low calcium levels), QT interval prolongation, and seizures. If you experience any unusual symptoms or side effects, contact your healthcare provider promptly.

In Summary:

Mimcipar 30mg Tablet containing Cinacalcet is a medication used to treat secondary hyperparathyroidism in patients with chronic kidney disease on dialysis and hypercalcemia associated with parathyroid carcinoma. It helps regulate parathyroid hormone levels and calcium metabolism, thereby reducing the risk of complications associated with abnormal calcium levels.